Future therapies for hepatocellular carcinoma
Sangro B, Mazzollini G, Prieto J.
The Liver Unit, Clínica Universitaria de Navarra, Fundación para la Investigación Médica Aplicada, University of Navarra, Pamplona, Spain.
A large proportion of patients with advanced hepatocellular carcinoma (HCC) lack effective therapy. Due to chemoresistance, hope has focused on other approaches including targeted therapies, immune stimulants, and the emerging area of gene therapy.
Increasing efforts in basic and clinical development of these approaches will hopefully result in more efficient therapies against HCC.
CITATION Eur J Gastroenterol Hepatol. 2005 May;17(5):515-21